HighPoint Advisor Group’s EnteroMedics Inc. ETRM Stock Holding History

HighPoint Advisor Group’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$21K	Buy	+37,067	New	+$21K	﹤0.01%	524
2021 Q3	$107K	Hold	37,067	–	–	0.01%	532
2021 Q2	$185K	Buy	+37,067	New	+$185K	0.02%	512

HighPoint Advisor Group's ETRM Position: Q2 2022 in Review

HighPoint Advisor Group opened a new position in EnteroMedics Inc. (ETRM) in Q2 2022: 37,067 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #524 among its holdings. This is a return to the name: HighPoint Advisor Group previously reported a position in ETRM as recently as Q3 2021.

HighPoint Advisor Group first reported a position in ETRM in Q2 2021 and has held it in 3 quarters since. The position peaked at $185K in Q2 2021. 1 fund tracked by Wall St. Rank holds ETRM as of Q2 2022.

HighPoint Advisor Group held 37,067 shares of EnteroMedics Inc. worth $21K as of Q2 2022.
EnteroMedics Inc. was a new HighPoint Advisor Group position in Q2 2022.
EnteroMedics Inc. made up ﹤0.01% of HighPoint Advisor Group's portfolio in Q2 2022, its #524 holding.
HighPoint Advisor Group first reported a position in EnteroMedics Inc. in Q2 2021 and has held it in 3 quarters since.
HighPoint Advisor Group's EnteroMedics Inc. position peaked at $185K in Q2 2021.
1 fund tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2022.

Based on HighPoint Advisor Group's 13F filing for Q2 2022, filed 15 Aug 2022.